Denosumab (Prolia)

Monoclonal antibody

Also known as AMG 162

Approvedregulatory verdict

Evidence outlook

Approved: Osteoporosis

Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.

Also approved (4)
US
  • Treatment of Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate Cancer Prolia is indicated as a treatment to increase bone mass in men at high risk for fracture receiving androgen deprivation therapy (ADT) for nonmetastatic prostate cancer. In these patients Prolia also reduced the incidence of vertebral fractures [see Clinical Studies (14.4) ] .
    FDA label
  • Treatment to increase bone mass in women at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancerOutside this platform's coverageFDA label
Product first approved 2010
JP
  • PRALIA (denosumab, Daiichi Sankyo): inhibition of the progression of bone erosion associated with rheumatoid arthritis
Product first approved 2017daiichisankyo.com
EU
  • Treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures. In postmenopausal women Prolia significantly reduces the risk of vertebral, non vertebral and hip fractures. Treatment of bone loss associated with hormone ablation in men with prostate cancer at increased risk of fractures. In men with prostate cancer receiving hormone ablation, Prolia significantly reduces the risk of vertebral fractures.
Product first approved 2010EMA

How the evidence outlook works ↗

All registered studies

Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase. Studies where this drug served as another program's comparator, or is merely referenced, are listed separately below.

Phase 3 (40)
Osteoporosis
NCT06504966 · Xentria, Inc.
2025-10 – 2027-10 · Osteoporosis
What this study did
NCT05853354 · Luye Pharma Group Ltd.
2023-04-05 – 2025-12-30 · Osteoporosis, Postmenopausal
What this study did
NCT06154707 · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
2024-02-01 – 2025-03-01 · Sarcopenia, Osteoporosis, Denosumab
What this study did
NCT03401060 · Assistance Publique - Hôpitaux de Paris
2018-03-05 – 2024-03-11 · Osteoporosis, Systemic Mastocytosis
What this study did
NCT03164928 · Amgen
2018-05-07 – 2023-12-20 · Evaluate the Safety and Efficacy of Denosumab in Pediatric Subjects With, Glucocorticoid-induced Osteoporosis
What this study did
NCT04034199 · Kwong Wah Hospital
2019-08-15 – 2021-03-31 · Idiopathic Inflammatory Myopathies, Osteoporosis, Osteopenia
What this study did
NCT03040765 · Hamad Medical Corporation
2018-05-14 – 2019-04-08 · Thalassemia Majors (Beta-Thalassemia Major), Osteoporosis
What this study did
NCT00925600 · Amgen
2009-11-30 – 2016-05-12 · Cancer, Cataract, Low Bone Mineral Density, Osteopenia, Osteoporosis, Prostate Cancer
What this study did
NCT01377467 · Rudolf Wuethrich
2011-06 – 2015-10 · Osteoporosis, Chronic Kidney Disease
What this study did
NCT02014467 · GlaxoSmithKline
2014-01 – 2015-08 · Osteoporosis, Postmenopausal
What this study did
NCT00523341 · Amgen
2007-08-07 – 2015-07-19 · Osteopenia, Osteoporosis
What this study did
NCT02157948 · Amgen
2014-05 – 2015-07 · Postmenopausal Osteoporosis
What this study did
NCT01457950 · GlaxoSmithKline
2011-11 – 2013-06 · Osteoporosis, Postmenopausal
What this study did
NCT01495000 · GlaxoSmithKline
2012-01 – 2013-02 · Osteoporosis, Postmenopausal
What this study did
NCT00680953 · Daiichi Sankyo Co., Ltd.
2008-05 – 2012-07 · Osteoporosis
What this study did
NCT00980174 · Amgen
2009-10-01 – 2012-05-23 · Low Bone Mass, Low Bone Mineral Density, Males With Osteoporosis, Osteopenia, Osteoporosis
What this study did
NCT00919711 · Amgen
2009-09-01 – 2012-03-05 · Osteoporosis
What this study did
NCT00890981 · Amgen
2009-07 – 2010-08 · Low Bone Mass, Low Bone Mineral Density, Osteoporosis, Postmenopausal Osteoporosis
What this study did
NCT00518531 · Amgen
2007-09-01 – 2010-06-01 · Osteoporosis
What this study did
NCT00091793 · Amgen
2004-08 – 2009-03 · Postmenopausal Osteoporosis
What this study did
NCT00515463 · Amgen
2007-05 – 2009-03 · Low Bone Mineral Density, Osteopenia, Osteoporosis
What this study did
NCT00377819 · Amgen
2006-09 – 2008-07 · Postmenopausal Osteoporosis
What this study did
Other / comorbidity
NCT04547348 · Ole Lander Svendsen
2020-11-01 – 2030-10-01 · Charcot Foot, Diabetes Mellitus
What this study did
NCT07056478 · Prince of Wales Hospital, Shatin, Hong Kong
2027-01-01 – 2030-01-01 · Sarcopenia in Elderly
What this study did
NCT03324932 · Kyoto Prefectural University of Medicine
2017-09-25 – 2027-12 · Breast Cancer
What this study did
NCT05638399 · Shenzhen People's Hospital
2020-01-15 – 2023-02-28 · Osteopenia, Lumbar Spondylolisthesis
What this study did
NCT00556374 · Amgen
2006-12-18 – 2022-07-26 · Breast Cancer
What this study did
NCT03638128 · Amgen
2018-07-26 – 2022-03-28 · Osteogenesis Imperfecta (OI)
What this study did
NCT02352753 · Amgen
2015-06-24 – 2022-03-26 · Osteogenesis Imperfecta
What this study did
NCT03292146 · Massachusetts General Hospital
2017-10-25 – 2021-07-22 · Bone Density, Bone Loss, Anorexia Nervosa, Eating Disorder, Atypical Anorexia Nervosa
What this study did
NCT03174366 · Western University of Health Sciences
2017-05-16 – 2019-03-06 · Charcot Joint of Foot
What this study did
NCT02567279 · University Hospital, Montpellier
2016-06-01 – 2019-01-03 · Anorexia Nervosa
What this study did
NCT00089674 · Amgen
2004-08-01 – 2010-05-11 · Prostate Cancer
What this study did
NCT00089661 · Amgen
2004-10-01 – 2009-05-27 · Breast Cancer, Low Bone Mineral Density, Osteopenia
What this study did
Phase 2/3 (4)
Osteoporosis
NCT04169698 · Ain Shams University
2019-10-17 – 2021-05-01 · Osteoporosis, Osteopenia, Renal Transplant Recipient
What this study did
Other / comorbidity
NCT05065164 · Shenzhen People's Hospital
2021-09-14 – 2023-09-25 · Denosumab Allergy
What this study did
NCT05106517 · Shenzhen People's Hospital
2021-09-08 – 2023-03-11 · Denosumab vs Zoledronate
What this study did
NCT05058443 · Shenzhen People's Hospital
2020-01-06 – 2022-08-10 · Osteoporotic Vertebral Compression Fracture
What this study did
Phase 2 (34)
Osteoporosis
NCT04800367 · Columbia University
2021-03-12 – 2028-03 · Premenopausal Idiopathic Osteoporosis
What this study did
NCT04608630 · Australian and New Zealand Intensive Care Research Centre
2021-07-15 – 2027-02-28 · Critical Illness, Osteoporosis
What this study did
NCT03755193 · Shinshu University
2018-11-24 – 2026-11-23 · Osteoporosis
What this study did
NCT03702140 · Shinshu University
2018-10-09 – 2025-10-08 · Osteoporosis
What this study did
NCT04231682 · Albert Einstein Healthcare Network
2020-07-01 – 2025-01-01 · Osteoporosis
What this study did
NCT03925532 · Roswell Park Cancer Institute
2019-12-19 – 2022-11-16 · Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Osteopenia, Osteoporosis
What this study did
NCT02049866 · Elizabeth Shane
2014-11-19 – 2021-12-23 · Adult Idiopathic Generalized Osteoporosis
What this study did
NCT03960554 · Thomas Nickolas, MD MS
2020-01-16 – 2021-12-02 · Osteoporosis, Renal Osteodystrophy, Kidney Transplant; Complications
What this study did
NCT03457818 · Mishaela Rubin
2018-11-07 – 2020-06-10 · Diabetes Mellitus, Type 2, Osteoporosis
What this study did
NCT02632916 · Children's Hospital of Eastern Ontario
2016-08 – 2020-02-03 · Osteoporosis
What this study did
NCT02132026 · University of Edinburgh
2014-11-12 – 2019-11-28 · Calcific Aortic Stenosis
What this study did
NCT02559648 · Ersi Voskaridou
2014-09 – 2017-12 · Thalassemia Major, Osteoporosis
What this study did
NCT00926380 · Massachusetts General Hospital
2009-06 – 2016-12 · Osteoporosis
What this study did
NCT00896532 · Amgen
2009-06-03 – 2016-02-18 · Low Bone Mineral Density, Postmenopausal Osteoporosis
What this study did
NCT00887965 · Amgen
2009-06 – 2010-08 · Low Bone Mass, Low Bone Mineral Density, Osteoporosis, Postmenopausal Osteoporosis
What this study did
Rheumatoid Arthritis
Other / comorbidity
NCT03571191 · National Institute of Dental and Craniofacial Research (NIDCR)
2019-06-13 – 2030-03-15 · Bone Diseases, Pain
What this study did
NCT04067726 · Washington University School of Medicine
2019-08-27 – 2027-09-30 · Dense Breasts
What this study did
NCT05419050 · National Institute of Dental and Craniofacial Research (NIDCR)
2022-10-12 – 2026-01-09 · Fibrous Dysplasia
What this study did
NCT05212337 · Martin Blomberg Jensen
2022-01-01 – 2025-09-30 · Infertility, Male
What this study did
NCT03620019 · UNC Lineberger Comprehensive Cancer Center
2018-09-10 – 2023-08-15 · Melanoma Stage Iii, Melanoma Stage Iv, Melanoma, Melanoma (Skin), Cutaneous Melanoma
What this study did
NCT03030196 · Martin Blomberg Jensen
2017-01 – 2023-05 · Infertility, Male
What this study did
NCT04403698 · University Hospital, Ghent
2019-11-13 – 2022-03-09 · Erosive Osteoarthritis
What this study did
NCT01358669 · Sheffield Teaching Hospitals NHS Foundation Trust
2011-12-14 – 2021-12-31 · Revision Surgery of Total Hip Arthroplasty
What this study did
NCT02771860 · University Hospital, Ghent
2016-03 – 2021-04-28 · Hand Osteoarthritis
What this study did
NCT02299817 · Olof Skoldenberg
2015-08 – 2021-02 · Osteolysis
What this study did
NCT02903446 · University of Alabama at Birmingham
2017-02-01 – 2020-03-01 · Gout
What this study did
NCT02422108 · Martin Blomberg Jensen
2015-05 – 2019-01 · Testis, Infertility, Sperm
What this study did
NCT01630941 · Hans Mallmin
2012-08-07 – 2017-03-30 · Osteoarthritis, Hip, Ambulation Difficulty
What this study did
NCT01799798 · University of Cologne
2013-02 – 2015-01 · Osteogenesis Imperfecta
What this study did
NCT00043186 · Amgen
2002-05 – 2007-06 · Low Bone Mineral Density
What this study did
Phase 1/2 (5)
Rheumatoid Arthritis
NCT02418273 · Indiana University
2019-08-01 – 2021-06 · Osteoporosis, Juvenile Rheumatoid Arthritis, Dermatomyositis, Polyarthritis, Systemic Lupus Erythematosis, Vasculitis, Glucocorticoid-induced Osteoporosis
What this study did
Other / comorbidity
NCT06524960 · City of Hope Medical Center
2025-05-05 – 2027-10-11 · Type 1 Diabetes
What this study did
NCT06706414 · Martin Blomberg Jensen
2025-03-01 – 2026-08-15 · Infertility, Male
What this study did
NCT06300229 · Martin Blomberg Jensen
2024-03-01 – 2025-08-31 · Infertility, Male
What this study did
NCT02321280 · University of Manitoba
2015-02 – 2018-04-20 · Crohn Disease
What this study did
Phase 1 (13)
Osteoporosis
NCT07085520 · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
2025-07-31 – 2026-05-31 · Osteoarthritis, Osteoarthritis (OA) of the Knee, Osteoporosis, Osteoporosis (Senile), Healthy
What this study did
NCT01221727 · Amgen
2010-11 – 2011-07 · Postmenopausal Osteoporosis
What this study did
Rheumatoid Arthritis
NCT01294397 · Amgen
2011-03 – 2016-01 · Postmenopausal, Osteopenia, Rheumatoid Arthritis, Osteoporosis
What this study did
Other / comorbidity
NCT04621318 · Samsung Bioepis Co., Ltd.
2020-10-19 – 2022-11-09 · Healthy
What this study did
NCT03427853 · Luye Pharma Group Ltd.
2018-01-10 – 2019-12-28 · Healthy Adults
What this study did
NCT02444585 · University of Southern California
2017-02-28 – 2019-12 · Arthroplasty, Replacement, Hip
What this study did
NCT02677246 · St. Justine's Hospital
2016-12 – 2018-09-04 · Disorder Related to Bone Marrow Transplantation
What this study did
NCT02554695 · Mayo Clinic
2015-10-20 – 2016-10-25 · Bone Loss, Aging
What this study did
NCT02053753 · Amgen
2014-02 – 2014-08 · Healthy Volunteer
What this study did
NCT02099461 · Amgen
2014-04 – 2014-07 · Healthy Volunteer, Female, Breast
What this study did
NCT01978483 · Innovaderm Research Inc.
2013-11 – 2014-06 · Ultraviolet Rays, Immunosuppression, Hypersensitivity, Delayed, Immune Tolerance/Drug Effects
What this study did
NCT01869686 · Amgen
2013-06 – 2013-09 · Healthy Volunteer
What this study did
Phase 4 (49)
Osteoporosis
NCT07772609 · Sahlgrenska University Hospital
2027-01-11 – 2031-12-31 · Osteoporosis in Post-menopausal Women
What this study did
NCT05091086 · National Taiwan University Hospital
2021-11-20 – 2030-12-31 · Osteoporosis, Bone Mineral Density
What this study did
NCT07909304 · Massachusetts General Hospital
2027-01 – 2030-12 · Postmenopausal Osteoporosis
What this study did
NCT06767150 · University Hospital, Toulouse
2025-10-02 – 2030-10 · Postmenopausal Osteoporosis
What this study did
NCT06938152 · National Taiwan University Hospital
2025-04-08 – 2029-12-31 · Osteoporosis, Osteoporosis Postmenopausal
What this study did
NCT06118905 · Chrissy Kistler
2024-02-08 – 2029-03-31 · Osteoporosis
What this study did
NCT07281586 · National Taiwan University Hospital
2026-01-01 – 2028-12-31 · Osteoporosis
What this study did
NCT07757373 · Tuen Mun Hospital
2026-09-01 – 2027-12-01 · Glucocorticoid-Associated Osteopenia and Osteoporosis
What this study did
NCT05010590 · Massachusetts General Hospital
2022-03-24 – 2027-11-01 · Postmenopausal Osteoporosis
What this study did
NCT06643780 · Prince of Wales Hospital, Shatin, Hong Kong
2024-04-09 – 2027-10 · Sarcopenia in Elderly
What this study did
NCT03921060 · University of Texas Southwestern Medical Center
2021-09-02 – 2027-07 · Cystic Fibrosis
What this study did
NCT06588153 · Amgen
2025-05-24 – 2027-04-27 · Glucocorticoid-induced Osteoporosis
What this study did
NCT07271771 · Aarhus University Hospital
2024-05-21 – 2027-03-01 · Osteoporosis
What this study did
NCT06332014 · Amgen
2024-08-06 – 2027-01-23 · Osteoporosis
What this study did
NCT04467983 · Hospital for Special Surgery, New York
2021-02-01 – 2026-12-31 · Osteoporosis, Postmenopausal
What this study did
NCT05666310 · Nami Safai Haeri
2023-02-14 – 2026-08-04 · Sarcopenia, Osteoporosis
What this study did
NCT05493761 · Aristotle University Of Thessaloniki
2022-12-23 – 2026-07-16 · Nonalcoholic Fatty Liver, Osteoporosis, Postmenopausal
What this study did
NCT06472050 · Tuen Mun Hospital
2024-08-20 – 2026-04-30 · Osteoporosis, Glucocorticoids Toxicity
What this study did
NCT05630768 · Dong-A ST Co., Ltd.
2023-01-03 – 2025-07-23 · Postmenopausal Osteoporosis
What this study did
NCT05884372 · Xi'an Honghui Hospital
2023-08-24 – 2025-07-16 · Osteoporosis in Postmenopausal Women
What this study did
NCT04177940 · University of Alabama at Birmingham
2020-08-17 – 2025-01-14 · Osteoporosis
What this study did
NCT03868033 · National Taiwan University Hospital
2019-04-12 – 2023-12-31 · Osteoporosis
What this study did
NCT04091243 · Tuen Mun Hospital
2021-01-15 – 2023-11-15 · Glucocorticoid-induced Osteoporosis
What this study did
NCT05203588 · Shanghai Changzheng Hospital
2021-10-09 – 2023-10 · Osteoporosis, Fusion of Spine, Lumbar Region
What this study did
NCT03623633 · Massachusetts General Hospital
2018-11-30 – 2023-08-01 · Osteoporosis, Postmenopausal, Osteoporosis
What this study did
NCT02753283 · Susan L. Greenspan
2016-06 – 2023-08 · Osteoporosis, Postmenopausal, Osteoporosis, Osteoporotic Fractures
What this study did
NCT04085419 · University Medical Centre Ljubljana
2019-05-08 – 2023-05 · Primary Hyperparathyroidism, Osteoporosis
What this study did
NCT02156960 · Shinshu University
2014-05 – 2022-11 · Osteoporosis
What this study did
NCT03029442 · James J. Peters Veterans Affairs Medical Center
2017-04-01 – 2022-10-06 · Secondary Osteoporosis, Spinal Cord Injury
What this study did
NCT03472846 · Medical University of Vienna
2017-03-01 – 2022-09-30 · Postmenopausal Osteoporosis, Diabetes Type 2
What this study did
NCT04026256 · Massachusetts General Hospital
2019-09-02 – 2022-04-18 · Postmenopausal Osteoporosis
What this study did
NCT02792413 · University Hospital, Montpellier
2018-11-19 – 2020-12-10 · Female With Osteoporosis and Chronic Kidney Disease
What this study did
NCT01983475 · James J. Peters Veterans Affairs Medical Center
2015-01 – 2020-05 · Osteoporosis, Spinal Cord Injury
What this study did
NCT03005678 · Tuen Mun Hospital
2017-04-01 – 2020-02-01 · Osteoporosis
What this study did
NCT02176382 · Massachusetts General Hospital
2014-08 – 2020-02 · Postmenopausal Osteoporosis
What this study did
NCT02130973 · Health Research, Inc.
2013-08 – 2018-08 · Osteoporosis
What this study did
NCT01732770 · Amgen
2012-11-07 – 2015-01-07 · Post Menopausal Osteoporosis
What this study did
NCT01750086 · Massachusetts General Hospital
2013-01 – 2014-08 · Postmenopausal Osteoporosis
What this study did
NCT01465568 · Tuen Mun Hospital
2011-12 – 2014-06 · Osteoporosis
What this study did
Rheumatoid Arthritis
NCT01770106 · Chinese University of Hong Kong
2012-12 – 2014-06 · Rheumatoid Arthritis
What this study did
Other / comorbidity
NCT05096195 · Western University, Canada
2022-06-11 – 2025-12 · Kidney Diseases, Dialysis; Complications, Fragility Fracture, Chronic Kidney Disease-Mineral and Bone Disorder
What this study did
NCT04087096 · Massachusetts General Hospital
2020-08-24 – 2024-08-06 · Bariatric Surgery Candidate, Bone Loss
What this study did
NCT05559268 · The Affiliated Hospital of Qingdao University
2022-10-01 – 2023-12-31 · Osteoarthritis, Knee
What this study did
NCT05598606 · Shenzhen People's Hospital
2021-01-12 – 2023-01-14 · Denosumab Allergy, Zoledronic Acid Allergy
What this study did
NCT01926158 · Turku University Hospital
2013-12 – 2017-12-31 · Hip Osteoarthritis
What this study did
NCT02853539 · Stanley Dudrick's Memorial Hospital
2011-01 – 2016-07 · Metabolic Bone Disease
What this study did
NCT01734824 · Medical University of Vienna
2012-05 – 2015-09 · Bone Marrow Oedema Syndrome, High Turnover Bone Disease, Quality of Life
What this study did
NCT02760979 · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
2013-01 – 2015-06 · Bone Resorption
What this study did
NCT01558115 · Columbia University
2012-01 – 2014-10 · Primary Hyperparathyroidism
What this study did
Early phase / not applicable (9)
Osteoporosis
NCT07546552 · Peter Humaidan
2025-08-01 – 2028-03-15 · Female Infertility, NF-κB Ligand, RANKL, Osteoporosis, Follicle Development
What this study did
NCT07063797 · Peking Union Medical College Hospital
2026-02-01 – 2027-07-31 · Type 2 Diabetes, Osteoporosis, Fractures
What this study did
NCT05372224 · Hospital Regional 1o de Octubre
2020-06-22 – 2021-06-22 · Hypovitaminosis D, Osteoporosis, Postmenopausal, Menopause
What this study did
NCT01572545 · Aristotle University Of Thessaloniki
2012-04 – 2013-01 · Postmenopausal Osteoporosis
What this study did
Rheumatoid Arthritis
NCT01973569 · Daiichi Sankyo
2013-10 – 2017-09-19 · Rheumatoid Arthritis
What this study did
Other / comorbidity
NCT05692297 · Capital Medical University
2023-01-01 – 2025-12-31 · Chronic Kidney Diseases, Fracture, Bone Density, Low, End Stage Renal Disease
What this study did
NCT05662358 · Shenzhen People's Hospital
2021-01-03 – 2023-10-25 · Denosumab Allergy
What this study did
NCT05415657 · Shenzhen People's Hospital
2020-01-12 – 2023-01-10 · Osteopenia, Spine Fusion, Denosumab Allergy
What this study did
NCT05736640 · University of Aarhus
2013-09-01 – 2016-09-30 · Osseointegrated Implants, Bone Mineral Density
What this study did
Used as active comparator (39)

Other programs' studies in which this drug was the registered active-comparator arm: a marker of standard-of-care status, not evidence of this drug's own progression.

Phase 3 (16)
Osteoporosis
NCT07062978 · Qilu Pharmaceutical Co., Ltd.
2025-06-27 – 2027-01 · Postmenopausal Women With Osteoporosis at High Risk of Fracture
What this study did
NCT06804590 · Mabwell (Shanghai) Bioscience Co., Ltd.
2024-11-16 – 2026-06-30 · Postmenopausal Women Osteoporosis
What this study did
NCT05419427 · Lambda Therapeutic Research Ltd.
2021-11-11 – 2024-11-24 · Osteoporosis, Postmenopausal
What this study did
NCT04591275 · Shanghai Biomabs Pharmaceutical Co., Ltd.
2021-03-31 – 2024-11-01 · Postmenopausal Osteoporosis
What this study did
NCT05395091 · Alvotech Swiss AG
2022-08-23 – 2024-10-28 · Osteoporosis, Postmenopausal
What this study did
NCT05405725 · Enzene Biosciences Ltd.
2022-07-04 – 2024-07-18 · Postmenopausal Osteoporosis
What this study did
NCT05352516 · Shanghai Henlius Biotech
2022-06-17 – 2024-07-03 · Postmenopausal
What this study did
NCT05345691 · Biocon Biologics UK Ltd
2022-05-24 – 2024-06-12 · Postmenopausal Women With Osteoporosis
What this study did
NCT05338086 · mAbxience Research S.L.
2022-03-16 – 2024-05-22 · Postmenopausal Women With Osteoporosis
What this study did
NCT04757376 · Celltrion
2021-06-17 – 2023-11-16 · Postmenopausal Women With Osteoporosis
What this study did
NCT05087030 · Gedeon Richter Plc.
2021-09-21 – 2023-11-15 · Postmenopausal Osteoporosis
What this study did
NCT04934072 · Fresenius Kabi SwissBioSim GmbH
2021-06-16 – 2023-08-07 · Postmenopausal Osteoporosis
What this study did
NCT04729621 · Teva Pharmaceuticals USA
2021-03-22 – 2023-06-19 · Osteoporosis, Postmenopausal
What this study did
NCT04664959 · Samsung Bioepis Co., Ltd.
2020-11-26 – 2023-01-03 · Postmenopausal Osteoporosis
What this study did
NCT03974100 · Sandoz
2019-07-02 – 2022-04-22 · Postmenopausal Women With Osteoporosis
What this study did
Other / comorbidity
NCT03027557 · Peter Vestergaard
2017-03-01 – 2019-09-12 · Primary Hyperparathyroidism, Parathyroid Adenoma, Parathyroid Hyperplasia
What this study did
Phase 2 (3)
Osteoporosis
NCT07806331 · Transcenta Therapeutics (Hangzhou) Co., Ltd.
2026-10-31 – 2028-10-31 · Postmenopausal Osteoporosis, Low Bone Mass
What this study did
NCT05278338 · Shanghai JMT-Bio Inc.
2022-04-21 – 2024-03-31 · Postmenopausal Osteoporosis
What this study did
Other / comorbidity
NCT04232657 · VA Office of Research and Development
2021-03-01 – 2026-08-24 · Spinal Cord Injury (=3 Years), Sublesional Bone Loss Secondary to SCI
What this study did
Phase 1 (15)
Osteoporosis
NCT04940845 · Shanghai Hansoh Biomedical Co., Ltd
2021-07-26 – 2022-06 · Postmenopausal Osteoporosis
What this study did
NCT04798313 · Mabwell (Shanghai) Bioscience Co., Ltd.
2020-06-02 – 2020-12-31 · Osteoporosis, Postmenopausal
What this study did
NCT03925051 · Shanghai Biomabs Pharmaceutical Co., Ltd.
2019-07-01 – 2020-06-18 · Postmenopausal Osteoporosis
What this study did
Other / comorbidity
NCT06310824 · Xentria, Inc.
2024-06-05 – 2025-07-22 · Healthy Participants
What this study did
NCT06361355 · Taizhou Mabtech Pharmaceutical Co.,Ltd
2023-11-02 – 2024-07-05 · Healthy Volunteers
What this study did
NCT05245669 · Enzene Biosciences Ltd.
2022-01-10 – 2024-05-22 · Healthy Male Subjects
What this study did
NCT05126784 · Alvotech Swiss AG
2022-06-29 – 2023-10-16 · Healthy Male Subjects
What this study did
NCT04534582 · Shanghai Henlius Biotech
2020-11-03 – 2023-09-12 · Healthy Male Volunteers
What this study did
NCT06037395 · Celltrion
2021-10-06 – 2022-10-20 · Healthy Subject
What this study did
NCT04973722 · Luye Pharma Group Ltd.
2020-12-09 – 2021-12-31 · Healthy Adults
What this study did
NCT04673799 · Kunming Pharmaceuticals, Inc.
2021-02-22 – 2021-10-18 · Healthy
What this study did
NCT04512872 · Celltrion
2020-10-20 – 2021-05-04 · Healthy Male Subjects
What this study did
NCT04213105 · Qilu Pharmaceutical Co., Ltd.
2019-10-31 – 2020-10-31 · Healthy People
What this study did
Phase 4 (5)
Osteoporosis
NCT06720350 · Marmara University
2025-01-15 – 2026-12-15 · Osteoporosis in Post-menopausal Women
What this study did
NCT07283887 · National Taiwan University Hospital
2025-12-03 – 2026-07-31 · Osteoporosis
What this study did
NCT02499237 · 424 General Military Hospital
2015-07 – 2018-11-26 · Postmenopausal Osteoporosis
What this study did
NCT01753856 · Eli Lilly and Company
2013-01 – 2014-06 · Osteoporosis
What this study did
Other / comorbidity
Appears in other studies (4)

Studies that reference this drug without giving it an intervention arm of its own: other formulations' programs, background therapy, or registry-search bleed.

Phase 3 (1)
Osteoporosis
NCT01575834 · Amgen
2012-03-15 – 2016-12-28 · Postmenopausal Osteoporosis
What this study did
Phase 4 (2)
Osteoporosis
NCT05101018 · James J. Peters Veterans Affairs Medical Center
2021-11-01 – 2027-11-01 · Osteoporosis, Spinal Cord Injuries
What this study did
NCT06272227 · Yonsei University
2024-02-13 – 2025-09-01 · Sarcopenia
What this study did
Early phase / not applicable (1)
Other / comorbidity
NCT05866029 · Peking Union Medical College Hospital
2023-05-26 – 2026-09-30 · Osteoporotic Fractures
What this study did

Competitive landscape

1 other tracked programme targets this mechanism, none of them ahead of this one.

This drug's own stage for Osteoporosis: Approved. Competitors below are sorted furthest-along first.

DrugStageModalityMechanismEvidence signalReported efficacygraded featured trials
Denosumab (Prolia): this drugApprovedMonoclonal antibodyRANKLnot yet gradedNo reviewed efficacy summary in this indication
Zoledronic Acid (Reclast)ApprovedSmall moleculeFarnesyl pyrophosphate synthase (FPPS)not yet gradedNo reviewed efficacy summary in this indication
Denosumab (Xgeva)
Phase 3(overall; approved for another use)
Monoclonal antibodyRANKL
Reliable signal(overall)
No reviewed efficacy summary in this indication
RT-102DiscontinuedPeptidePTH1 receptornot yet gradedNo reviewed efficacy summary in this indication

Upcoming events

(20 total)

Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.

Follow Denosumab (Prolia) to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.

Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

2027 (11)
January 2027 (1)
Phase 4OsteoporosisActive not recruiting
Est. primary completion 2027-01-23 · NCT06332014 · CT.gov ↗
What to watch
February 2027 (1)
Phase 2OsteoporosisRecruiting
Est. primary completion 2027-02-28 · NCT04608630 · CT.gov ↗
What to watch
March 2027 (2)
Phase 2OsteoporosisActive not recruiting
Est. primary completion 2027-03 · NCT04800367 · CT.gov ↗
What to watch
Phase 4OsteoporosisRecruiting
Est. primary completion 2027-03-01 · NCT07271771 · CT.gov ↗
What to watch
April 2027 (2)
Phase 4OsteoporosisRecruiting
Est. primary completion 2027-04 · NCT06643780 · CT.gov ↗
What to watch
Phase 4OsteoporosisActive not recruiting
Est. primary completion 2027-04-27 · NCT06588153 · CT.gov ↗
What to watch
July 2027 (2)
Phase 4OsteoporosisRecruiting
Est. primary completion 2027-07 · NCT03921060 · CT.gov ↗
What to watch
Early phase / not applicableOsteoporosisNot yet recruiting
Est. primary completion 2027-07-31 · NCT07063797 · CT.gov ↗
What to watch
September 2027 (1)
Phase 4OsteoporosisNot yet recruiting
Est. primary completion 2027-09-30 · NCT07757373 · CT.gov ↗
What to watch
October 2027 (2)
Phase 4OsteoporosisActive not recruiting
Est. primary completion 2027-10-01 · NCT05010590 · CT.gov ↗
What to watch
Phase 1/2Type 1 DiabetesRecruiting
Est. primary completion 2027-10-11 · NCT06524960 · CT.gov ↗
What to watch
2028 (3)
January 2028 (1)
Phase 3Sarcopenia in ElderlyNot yet recruiting
Est. primary completion 2028-01-01 · NCT07056478 · CT.gov ↗
What to watch
March 2028 (1)
Early phase / not applicableOsteoporosisRecruiting
Est. primary completion 2028-03-15 · NCT07546552 · CT.gov ↗
What to watch
December 2028 (1)
Phase 4OsteoporosisRecruiting
Est. primary completion 2028-12-31 · NCT07281586 · CT.gov ↗
What to watch
2029 (3)
February 2029 (1)
Phase 4OsteoporosisRecruiting
Est. primary completion 2029-02-28 · NCT06118905 · CT.gov ↗
What to watch
April 2029 (1)
Phase 4OsteoporosisRecruiting
Est. primary completion 2029-04-30 · NCT06938152 · CT.gov ↗
What to watch
December 2029 (1)
Phase 4OsteoporosisNot yet recruiting
Est. primary completion 2029-12-31 · NCT07772609 · CT.gov ↗
What to watch
2030 (3)
August 2030 (1)
Phase 3Charcot Foot, Diabetes MellitusRecruiting
Est. primary completion 2030-08-01 · NCT04547348 · CT.gov ↗
What to watch
October 2030 (1)
Phase 4OsteoporosisRecruiting
Est. primary completion 2030-10 · NCT06767150 · CT.gov ↗
What to watch
December 2030 (1)
Phase 4OsteoporosisNot yet recruiting
Est. primary completion 2030-12 · NCT07909304 · CT.gov ↗
What to watch

See the full readout calendar ↗